A multicenter study of recombinant factor VIII (Recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A - Bray, G L; Gomperts, E D; Courter, S; Gruppo, R; Gordon, E M; Manco-Johnson, M; Shapiro, A; Scheibel, E; White, G, III; Lee, M (Blood, 1994)
and the Recombinate Study Group